Showing results (41-50 of 317) with videos related to
Sort By:
Pageof 32
Journal of Immunogenetics|August 1, 1983
H-2K restriction of the T cell-mediated lysis of a chemically-induced BALB/c fibrosarcomaM P Colombo, M Rodolfo, G ParmianiJournal of the National Cancer Institute|February 1, 1983
Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cellsM L Sensi, M Parenza, G ParmianiLa Ricerca in Clinica E in Laboratorio|July 1, 1980
The undefined relationship between tumor antigens and histocompatibility antigens on cancer cellsG Parmiani, G Fossati, G Della PortaInternational Journal of Cancer|December 15, 1984
Passive adoptive immunotherapy of low-immunogenic BALB/c lymphoma by syngeneic alloimmune T lymphocytesM P Colombo, I Arioli, G ParmianiInternational Journal of Clinical & Laboratory Research|January 1, 1992
Cytokine gene transfer in tumor cells as an approach to antitumor therapyM P Colombo, S Mattei, G ParmianiAnnals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2012
Melanoma as a model tumour for immuno-oncologyM MaioImmunology Letters|September 21, 2000
Cytokines in cancer therapyG Parmiani, L Rivoltini, G Andreola, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2000
Tumour immunotherapy: the adjuvant treatment of the 21st century?A J Bremers, P J Kuppen, G ParmianiInternational Journal of Cancer|October 15, 1986
Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gammaA Anichini, R Mortarini, G Fossati, et al.International Journal of Cancer|September 15, 1990
Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive abilityA Anichini, R Mortarini, R Supino, et al.Pageof 32